Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Other financing activities (2022 - 2026)

Axsome Therapeutics' Other financing activities history spans 5 years, with the latest figure at $95000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities fell 75.83% to $95000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $899000.0, a 25.64% decrease, with the full-year FY2025 number at $1.2 million, up 46.69% from a year prior.
  • Other financing activities hit $95000.0 in Q1 2026 for Axsome Therapeutics, up from -$2.4 million in the prior quarter.
  • Over the last five years, Other financing activities for AXSM hit a ceiling of $12.4 million in Q2 2023 and a floor of -$2.4 million in Q4 2025.
  • Historically, Other financing activities has averaged $2.0 million across 5 years, with a median of $455000.0 in 2025.
  • The widest YoY moves for Other financing activities: up 941.22% in 2025, down 841.95% in 2025.
  • Tracing AXSM's Other financing activities over 5 years: stood at $6.5 million in 2022, then plummeted by 68.46% to $2.0 million in 2023, then plummeted by 83.92% to $329000.0 in 2024, then crashed by 841.95% to -$2.4 million in 2025, then soared by 103.89% to $95000.0 in 2026.
  • Business Quant data shows Other financing activities for AXSM at $95000.0 in Q1 2026, -$2.4 million in Q4 2025, and $2.7 million in Q3 2025.